REducing Salt Intake for Prevention of CardioVascular Disease in high risk patients: a cluster randomized trial of advanced health education intervention in northern Thailand (RESIP-CVD study)

Ministry of Education, Culture, Sports, Science and Technology (Japan)0 个研究点目标入组 753 人开始时间: 2012年1月3日最近更新: 2021年2月1日

适应症

试验速览

•1. Diabetic patients with high risk of cardiovascular risk by General Framingham scoring 10 years risk (>15%)
•2. Hypertensive patients with high risk of cardiovascular risk by Framingham scoring (>15%)
•3. Patient who are willing to participate in the study

•1. Any female patients who are pregnant
•2. Patients aged younger than 35 years
•3. Patients with documented type I diabetes
•4. Those on long term steroid therapy (more than 2 weeks)
•5. Those on long term non-steroidal anti-inflammatory drugs (NSAIDs) (i.e. every day for at least one year)
•6. Patients with cancer
•7. Patients with known secondary hypertension such as primary aldosteronism, cushing disease syndrome or Pheochromocytoma
•8. Patients with severe chronic pulmonary diseases using home oxygen therapy
•9. Patients with chronic renal disease (Creatinine?2.0 mg/dl)
•10. Patients with Congestive Heart Failure

发起方

Ministry of Education, Culture, Sports, Science and Technology (Japan)